Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital

Int J Antimicrob Agents. 2021 Jan;57(1):106245. doi: 10.1016/j.ijantimicag.2020.106245. Epub 2020 Nov 27.

¹ Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
² Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy; Sapienza University Hospital 'Policlinico Umberto I', Rome, Italy.
³ Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
⁴ Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.
⁵ Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
⁶ Sapienza University of Rome, Department of Anesthesia and Critical Care Medicine, Policlinico Umberto I, Rome, Italy.
⁷ Sapienza University Hospital 'Policlinico Umberto I', Rome, Italy.
⁸ Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy; Sapienza University Hospital 'Policlinico Umberto I', Rome, Italy. Electronic address: [email protected].

No abstract available

Keywords: COVID-19; Carbapenemase; Hospital-acquired infection; Intensive care unit; Klebsiella pneumoniae.

Publication types